Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 19:16:467-479.
doi: 10.2147/CCIDE.S488206. eCollection 2024.

Platelet-Rich Fibrin (PRF) Analyzed for Cytokine Profiles - A Misguided Hope for Osteogenesis in Jawbone Defects? Research and Clinical Observational Study

Affiliations

Platelet-Rich Fibrin (PRF) Analyzed for Cytokine Profiles - A Misguided Hope for Osteogenesis in Jawbone Defects? Research and Clinical Observational Study

Johann Lechner et al. Clin Cosmet Investig Dent. .

Abstract

Background: Platelet-rich fibrin (PRF) blood concentrates are used in oral implantology and defect surgery to promote osteoneogenesis in Bone Marrow Defects in Jawbone (BMDJ), according to the morphology of fatty-degenerative osteonecrosis also called FDOJ.

Question: Can the benefit of PRF on alveolar osteoneogenesis be confirmed by cytokine analysis?.

Methods: The cytokine expressions of the PRF samples in 26 patients undergoing BMDJ/FDOJ surgery in the same session were analysed for seven cytokines (RANTES/CCL5; FGF-2; IL-1RA; Il-6; IL-8; MCP-1; TNF-a) by multiplex (Luminex). The FDOJ samples of these 26 BMDJ/FDOJ patients were analysed for the RANTES/CCL5 expression only.

Results: Cytokine expression in PRF is compared to reference values for healthy medullary bone of the jaw and BMDJ/FDOJ and shows that the cytokine expressions of the PRF samples do not compensate or counteract prima vista for the cytokine dysregulations present in the BMDJ/FDOJ areas.

Discussion: To define the aid of cytokines studied in PRF in the restoration of the immunological dysregulation in areas of BMDJ/FDOJ, literature is reviewed comparing RANTES/CCL5, IL-1ra, TNF-α and MCP-1/CCL2 expression in PRF and BMDJ/FDOJ. Immunoregulatory properties of PRF in alveolar bone restoration are evaluated.

Summary: PRF was mistakenly thought to be a cure for bone healing, which is here shown to be incorrect. Enoral Ultrasound Sonography of bone density is available for the clinical measurement of individually developed osteoneogenesis by PRF.

Conclusion: The multiplex analysis of PRF shows a dynamic and cytokine-based interaction with osteoneogenesis that is not yet fully clarified.

Keywords: bone marrow defects of the jaw; cytokines; enoral transalveolar ultrasonograph; multiplex analysis; osteoneogenesis; platelet-rich fibrin.

PubMed Disclaimer

Conflict of interest statement

Drs Johann Lechner reports a patent Europäisches Patent 3720382 PCT/EP2018/084199 issued to Dr. Johann Lechner. The authors report no other conflicts of interest in this work..

Figures

None
Graphical abstract
Figure 1
Figure 1
Legend: Columns in red (MV) show the mean value of the respective cytokine in 128 BMDJ/FDOJ samples; columns in blue (Norm) show the mean value of each cytokine in 19 healthy jaw bone samples. The distribution of the multiplex analyses of 128 BMDJ/FDOJ samples shows marked singular overexpression of R/C, mild overexpression of IL-1ra (red arrows) and highly downregulated TNF-α and IL-6 expression (blue arrows). (*) Indicate medium values of cytokine expressions in BMDJ/FDOJ samples. The inset image shows one of the characteristic samples of fatty-degenerative osteonecrosis of the jaw (FDOJ) which was evaluated using a cytokine panel analysis.
Figure 2
Figure 2
Graphical statistics of. Figure 1: MV FDOJ = 128 show the mean value of the respective cytokine in 128 BMDJ/FDOJ samples; Norm = 19 show the mean value of each cytokine in 19 healthy jaw bone samples.
Figure 3
Figure 3
From left to right: PRF clot frozen transport to laboratory for Multiplex analysis (Luminex) for a seven cytokine panel (RANTES/CCL5, FGF-2, IL1-RA, Il-6, IL-8, MCP-1, and TNF-α: See Figure 2).
Figure 4
Figure 4
Areas of BMDJ/FDOJ. The left panel shows a hollow cavity in areas 38–39 after curettage of a softened, spongy bone marrow defect of the jaw (BMDJ). The right panel shows a clump of tissue displaying fatty degeneration of bone marrow (FDOJ) with the typical yellowish coloring characteristic of this fatty transformation.
Figure 5
Figure 5
Distribution of cytokine expression of PRF samples from 26 patients as determined by multiplex analysis of the following cytokines in pg/mL: R/C, FGF-2, IL1-RA, IL-6, IL-8, MCP-1 and TNF-α.
Figure 6
Figure 6
Graphical statistics to Figure 5: Left picture: Results of RANTES/CCL5 expression in 26 PRF samples (MV = 9.212,19 pg/mL; StDev = ±7.352,03 pg/mL). Right picture: Results of RANTES/CCL5 expression in 26 BMDJ/FDOJ samples of same patients as PRF (MV = 2.766,88 pg/mL; StDev = ±3.399,78 pg/mL).
Figure 7
Figure 7
Comparison of cytokine expression patterns observed in the 7-cytokine panel for 19 samples of healthy medullary bone of the jaw (green columns), for 128 BMDJ/FDOJ samples where we added the new R/C of 26 actually debrided BMDJ/FDOJ samples (red columns), and 26 PRF samples (blue columns).
Figure 8
Figure 8
Hypothetical mechanism of aim of PRF (yellow columns), ie, balancing the pathological cytokine profile of BMDJ/FDOJ by upregulating TH-1 acute cytokines IL-6, MCP-1 and TNF-α, (red arrows), and downregulating TH-2 cytokines, (blue arrows).

Similar articles

References

    1. Amengual-Penafiel L, Cordova LA, Constanza Jara-Sepulveda M, Branes- Aroca M, Marchesani-Carrasco F, Cartes-Velasquez R. Osteoimmunology drives dental implant osseointegration: a new paradigm for implant dentistry. Jpn Dent Sci Rev. 2021;57:12–19. doi:10.1016/j.jdsr.2021.01.001 - DOI - PMC - PubMed
    1. Lechner J, Schulz T, von Baehr V. Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects—osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine. EPMA J. 2019;1–14. doi:10.1007/s13167-019-00182-1 - DOI - PMC - PubMed
    1. Bar-Shavit Z. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem. 2007;102(5):1130–1139. doi:10.1002/jcb.21553 - DOI - PubMed
    1. Wang X, Li Y, Feng Y, Cheng H, Li D. The role of macrophages in osseointegration of dental implants: an experimental study in vivo. J BioMed Mater Res A. 2020;108(11):2206–2216. doi:10.1002/jbm.a.36978 - DOI - PubMed
    1. McDade TW. Early environments and the ecology of inflammation. Proc Natl Acad Sci U S A. 2012;109 Suppl 2:17281–17288. doi:10.1073/pnas.1202244109 - DOI - PMC - PubMed